Custom Search


Tuesday 01 August 2000

Is there a clinical difference in outcomes when beta-agonist therapy is delivered through metered-dose inhaler (MDI) with a spacing device compared with standard nebulizer treatments in acutely wheezing children?

By: Stephens MB.

J Fam Pract 2000 Aug;49(8):760-1

No abstract available

Use of this site is subject to the following terms of use